Rankings
▼
Calendar
INSM FY 2018 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena
INSM
Insmed Incorporated
$30B
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$10M
Gross Profit
$7M
75.4% margin
Operating Income
-$307M
-3124.9% margin
Net Income
-$324M
-3297.2% margin
EPS (Diluted)
$-4.22
Cash Flow
Operating Cash Flow
-$258M
Free Cash Flow
-$273M
Stock-Based Comp.
$26M
Balance Sheet
Total Assets
$605M
Total Liabilities
$396M
Stockholders' Equity
$208M
Cash & Equivalents
$495M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$10M
$0
—
Gross Profit
$7M
-$3M
+355.5%
Operating Income
-$307M
-$189M
-62.7%
Net Income
-$324M
-$193M
-68.3%
← Q4 2017
All Quarters
Q1 2018 →